As a business unit of RTI International, we provide global biopharmaceutical companies research and consulting services in health economics, patient-centered outcomes research, market access, and pharmacoepidemiology. As the only non-profit, independent organization of its kind, our multidisciplinary team of over 350 professionals--most of them master's- and PhD-level researchers--brings a balanced approach of scientific rigor and industry context to projects.